Next Science Limited
ASX:NXS.AX
0.12 (AUD) • At close February 5, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) AUD.
| 2024 Q2 | 2023 Q4 | 2023 Q2 | 2022 Q4 | 2022 Q2 | 2021 Q4 | 2021 Q2 | 2020 Q4 | 2020 Q2 | 2019 Q4 | 2019 Q2 | 2018 Q4 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 11.234 | 12.591 | 9.941 | 6.429 | 5.176 | 4.987 | 3.81 | 2.533 | 1.112 | 1.763 | 2.322 | 1.021 |
| Cost of Revenue
| 2.272 | 3.383 | 3.751 | 2.128 | 1.314 | 1.159 | 0.816 | 0.796 | 4.737 | 4.564 | 4.535 | 0.138 |
| Gross Profit
| 8.962 | 9.208 | 6.19 | 4.301 | 3.862 | 3.828 | 2.994 | 1.737 | -3.624 | -2.801 | -2.213 | 0.882 |
| Gross Profit Ratio
| 0.798 | 0.731 | 0.623 | 0.669 | 0.746 | 0.768 | 0.786 | 0.686 | -3.258 | -1.589 | -0.953 | 0.864 |
| Reseach & Development Expenses
| 3.336 | 3.258 | 3.306 | 3.212 | 2.872 | 2.513 | 2.444 | 5.205 | 1.107 | 0.714 | 1.026 | 0.435 |
| General & Administrative Expenses
| 3.205 | 2.976 | 2.624 | 2.093 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.657 |
| Selling & Marketing Expenses
| 8.698 | 11.05 | 9.077 | 5.647 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.163 |
| SG&A
| 11.903 | 14.043 | 11.014 | 7.301 | 7.311 | 6.593 | 4.717 | 2.49 | 2.568 | 2.66 | 3.22 | 2.82 |
| Other Expenses
| -0.416 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2.62 |
| Operating Expenses
| 14.823 | 17.302 | 14.32 | 10.513 | 10.182 | 9.105 | 7.161 | 7.695 | 3.676 | 3.375 | 4.246 | 0.636 |
| Operating Income
| -5.861 | -8.094 | -8.129 | -6.212 | -6.321 | -5.277 | -4.167 | -5.958 | -7.3 | -6.175 | -6.459 | -3.079 |
| Operating Income Ratio
| -0.522 | -0.643 | -0.818 | -0.966 | -1.221 | -1.058 | -1.094 | -2.352 | -6.563 | -3.503 | -2.782 | -3.017 |
| Total Other Income Expenses Net
| 0.02 | 0.104 | -0.338 | -0.007 | 0.018 | 0.174 | 0.08 | 0.422 | 0.234 | -1.811 | -0.051 | -0.052 |
| Income Before Tax
| -5.84 | -7.99 | -8.467 | -6.218 | -6.303 | -5.103 | -4.087 | -5.535 | -7.066 | -7.986 | -6.514 | -3.607 |
| Income Before Tax Ratio
| -0.52 | -0.635 | -0.852 | -0.967 | -1.218 | -1.023 | -1.073 | -2.185 | -6.353 | -4.53 | -2.805 | -3.534 |
| Income Tax Expense
| -0 | 0 | -0 | -0 | -0 | -0 | 0 | 0 | 0 | -0 | -0 | 0.528 |
| Net Income
| -5.84 | -7.99 | -8.467 | -6.218 | -6.303 | -5.103 | -4.087 | -5.535 | -7.066 | -7.986 | -6.514 | -4.135 |
| Net Income Ratio
| -0.52 | -0.635 | -0.852 | -0.967 | -1.218 | -1.023 | -1.073 | -2.185 | -6.353 | -4.53 | -2.805 | -4.052 |
| EPS
| -0.03 | -0.031 | -0.039 | -0.029 | -0.031 | -0.026 | -0.021 | -0.029 | -0.039 | -0.044 | -0.043 | -0.025 |
| EPS Diluted
| -0.03 | -0.031 | -0.039 | -0.029 | -0.031 | -0.026 | -0.021 | -0.029 | -0.039 | -0.044 | -0.043 | -0.025 |
| EBITDA
| -5.261 | -6.984 | -7.607 | -5.652 | -5.936 | -4.781 | -3.795 | -5.145 | -6.691 | -5.788 | -6.201 | -7.632 |
| EBITDA Ratio
| -0.468 | -0.595 | -0.765 | -0.878 | -1.158 | -0.995 | -1.02 | -2.202 | -6.237 | -3.326 | -2.671 | -2.878 |